ChemRar High-Tech Center-Pharmaceuticals & Healthcare-Deals and Alliances Profile

ChemRar High-Tech Center-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH336922D
  • |
  • Pages: 37
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

ChemRar High-Tech Center (CHTC) is a discovers and commercializes drugs for life-threatening diseases. The company offers drugs for the treatment of cancer, central nervous system (CNS), infectious, metabolic and cardiovascular diseases. It also offers pre-clinical and clinical research of new molecules including screening and identification of the important biological targets for new molecules, synthesis and research of new molecules, and manufacturing. CHTC also invests in companies with drug candidates in early development stage which ranges from pre-clinical stage to Phase II clinical trials. The company offers its services in Japan and Russia. CHTC is headquartered in Khimki, Russia.

ChemRar High-Tech Center-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

ChemRar High-Tech Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

ChemRar High-Tech Center, Medical Devices Deals, 2011 to YTD 2017 10

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

Regen BioPharma Enters into Agreement with ChemDiv 13

Janssen Research & Development Enters into Agreement with ChemDiv 13

ChemDiv, Torrey Pines Investment and DZNE Enter into Research Agreement 14

National Immunobiological Forms Joint Venture with ChemRar HTC 15

ChemDiv Enters into Agreement with Cystic Fibrosis Foundation Therapeutics 16

ChemRar High Tech Center Enters into Agreement with Lancet to Develop Novel Drugs in Russia 17

ChemDiv Enters into R&D Agreement with UCSD, MIPT and SatRx 17

Dompe Farmaceutici Enters Into Co-Development Agreement With SatRx For Reparixin 18

MIPT, Wi2 And ChemDiv Research Institute Partner To Develop Therapeutics For Human Health 19

Coare Biotech Enters Into Agreement With ChemDiv To Offer Gene-To-Clinic Services 20

ChemDiv Research Institute Expands Co-Development Agreement with Abbott Labs 21

ChemDiv Enters Into Research Agreement With Janssen Pharmaceutica And Tibotec Pharma 22

ChemRar High Tech Center Enters Into Co-Development Agreement With Janssen Pharma 22

Emerald BioStructures Enters Into Co-Marketing Agreement With ChemDiv 23

ChemRar Enters Into Co-Development Agreement With Genzyme 24

Licensing Agreements 25

NewVac Enters Into Licensing Agreement With Janssen For Quisinostat 25

Pfizer Enters Into Licensing Agreement With SatRx For PF-00734200 26

Agenus Enters Into Licensing And Development Agreement With NewVac For Oncophage 27

ChemDiv Research Institute Enters Into Licensing Agreement With Novartis Institute for Tropical Diseases For Tuberculosis 28

Equity Offering 29

Viriom Raises USD2.35 Million in Private Placement of Shares 29

ChemRar High-Tech Center-Key Competitors 31

Key Employees 32

Locations And Subsidiaries 33

Head Office 33

Other Locations & Subsidiaries 33

Recent Developments 35

Strategy And Business Planning 35

Jul 21, 2016: Abbott considers further expansion of Russian business 35

Product News 36

Jul 07, 2016: Tomsk scientists develop non-addictive pain reliever 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37

List of Figures

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

ChemRar High-Tech Center, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Key Facts 1

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

ChemRar High-Tech Center, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

ChemRar High-Tech Center, Deals By Therapy Area, 2011 to YTD 2017 9

ChemRar High-Tech Center, Medical Devices Deals, 2011 to YTD 2017 10

ChemRar High-Tech Center, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Regen BioPharma Enters into Agreement with ChemDiv 13

Janssen Research & Development Enters into Agreement with ChemDiv 13

ChemDiv, Torrey Pines Investment and DZNE Enter into Research Agreement 14

National Immunobiological Forms Joint Venture with ChemRar HTC 15

ChemDiv Enters into Agreement with Cystic Fibrosis Foundation Therapeutics 16

ChemRar High Tech Center Enters into Agreement with Lancet to Develop Novel Drugs in Russia 17

ChemDiv Enters into R&D Agreement with UCSD, MIPT and SatRx 17

Dompe Farmaceutici Enters Into Co-Development Agreement With SatRx For Reparixin 18

MIPT, Wi2 And ChemDiv Research Institute Partner To Develop Therapeutics For Human Health 19

Coare Biotech Enters Into Agreement With ChemDiv To Offer Gene-To-Clinic Services 20

ChemDiv Research Institute Expands Co-Development Agreement with Abbott Labs 21

ChemDiv Enters Into Research Agreement With Janssen Pharmaceutica And Tibotec Pharma 22

ChemRar High Tech Center Enters Into Co-Development Agreement With Janssen Pharma 22

Emerald BioStructures Enters Into Co-Marketing Agreement With ChemDiv 23

ChemRar Enters Into Co-Development Agreement With Genzyme 24

NewVac Enters Into Licensing Agreement With Janssen For Quisinostat 25

Pfizer Enters Into Licensing Agreement With SatRx For PF-00734200 26

Agenus Enters Into Licensing And Development Agreement With NewVac For Oncophage 27

ChemDiv Research Institute Enters Into Licensing Agreement With Novartis Institute for Tropical Diseases For Tuberculosis 28

Viriom Raises USD2.35 Million in Private Placement of Shares 29

ChemRar High-Tech Center, Key Competitors 31

ChemRar High-Tech Center, Key Employees 32

ChemRar High-Tech Center, Subsidiaries 33

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

ChemRar High-Tech Center, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16005
Site License
USD 500 INR 32010
Corporate User License
USD 750 INR 48015

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com